Symbolic Capital Research
Investment Thesis
Symbolic Capital describes itself as a people-driven investment firm supporting the best web3 founders globally. The partners say trends and technology change but people do not, so they back founders on trust and conviction and aim for a lasting partnership rather than a one-off check. They also offer to tell portfolio founders' stories publicly. The firm was launched by Sandeep Nailwal, co-founder of Polygon, and Kenzi Wang, co-founder of Cere, who met at Binance Labs in 2019 and had co-invested in more than 40 companies as angels before forming the fund.
At launch in 2022 the stated focus was consumer-facing decentralized apps and the creator economy, with a plan to put most capital behind founders from emerging markets. Since then the portfolio has moved toward blockchain infrastructure (data availability, restaking, zero-knowledge proofs, Bitcoin layers, interoperability) and crypto-AI (decentralized AI data, inference, verification and agent networks).
Stage Focus
Seed is the dominant stage. Public deal databases list nearly all of the firm's recorded rounds as seed or similar early equity rounds. The firm also invests in the earliest rounds of companies that are already in the partners' networks.
Check Size
Symbolic Capital does not publish a check size. Recorded rounds it joined range from about $2M to $85M in total round size, with most between $5M and $25M, so its own checks are likely small participations in those rounds.
Lead Tendency
The firm mostly participates in rounds led by other funds. One recorded lead is GenFlux (a $4M seed in February 2026). Frequent co-investors include dao5, Hack VC, Nomad Capital, Polychain Capital, Polygon Ventures, Dispersion Capital, HashKey Capital and OKX Ventures.
Recent Activity
The firm raised a $50M fund in 2022. Recent recorded activity includes a participation in Dataline's $11M seed (October 2026), Sentient (2026), a lead of GenFlux's $4M seed (February 2026), and Neuramint (January 2026). Earlier deals include Miden, Fluent, PIN AI, OpenGradient, ZEROBASE, Prodia and Moso. It announced investments in Primus (February 2025) and TAC (November 2024). It remains an active investor.
Portfolio Highlights
The public portfolio lists about 40 companies, including Polyhedra, 0G Labs, Babylon, Nillion, Sentient, Vana, Avantis, StakeStone, Nubit, Inco Network, Morph, Fluent, Primus, ORA, Mira, EZKL, Prodia, PIN AI, Compute Labs, Skate and TAC. Earlier consumer and gaming names include Community Gaming, Blinkmoon, Memeland and Mystic Moose.
Team
- Sandeep Nailwal, Co-Founder: co-founder of Polygon. He says he was turned down by every VC when raising Polygon's first round and set up Symbolic to back underdogs on merit rather than connections. His first question to founders is whether they have grit.
- Kenzi Wang, Co-Founder: co-founder of Cere, early Huobi employee who opened its US office, and a founder with a web2 exit. He looks for a fierce refusal to accept the status quo.
- Chad Liu, Investor: Wharton MBA and a DeFi insurance protocol founder since 2020. He co-authors the firm's research.
Decision Process
The partners are hands-on and relationship-led. The firm does not publish a formal process; decisions appear to rest with the two co-founders.
Founder Preferences
The firm favors resilient, technically capable web3 founders with grit, contrarian conviction and a willingness to build in the open. It supports founders from emerging markets and runs the Nailwal Fellowship, which gives $50,000 in grant money to about ten fellows each year for six months of building in web3, with technical founders preferred. Applications open from May into June.
Geographic Focus
The firm is based in New York. Deals are mostly with US companies, with others in Singapore, Europe, Hong Kong, Israel and Canada. It also targets founders from emerging markets, particularly India and Southeast Asia.
Research and Content
The firm publishes research and essays, including pieces on BitVM, Babylon restaking, frontier AI training and reinforcement-learning environments.